Steen Meier Rønborg
Corporate Officer/Principal chez University of Copenhagen
Profil
Steen Meier Rønborg is the founder of Alsensa ApS, which was founded in 2000.
He held the title of Administrative Director from 2010 to 2012.
Currently, he is a Principal at the University of Copenhagen.
Dr. Rønborg has an undergraduate and doctorate degree from the University of Copenhagen.
Postes actifs de Steen Meier Rønborg
| Sociétés | Poste | Début |
|---|---|---|
| University of Copenhagen | Corporate Officer/Principal | 03/07/2009 |
Anciens postes connus de Steen Meier Rønborg
| Sociétés | Poste | Fin |
|---|---|---|
Alsensa ApS
 Alsensa ApS Miscellaneous Commercial ServicesCommercial Services Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market. | Fondateur | 15/04/2010 |
Formation de Steen Meier Rønborg
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Alsensa ApS
Alsensa ApS Miscellaneous Commercial ServicesCommercial Services Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market. | Commercial Services |